PERCEPTIVE ADVISORS LLC

Position in CELC — Celcuity Inc.

CIK 1224962 NEW YORK, NY

Position in CELC

as of Mar 31, 2026 · filed May 29, 2026 Compact

Position Value

$356,938,608

+$41,740,260 QoQ

Shares Held

3,127,200

-1.0% QoQ

Ownership

6.41%

of shares outstanding

% of Portfolio

7.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PERCEPTIVE ADVISORS LLC holds $4,570,707,559 across 67 Biotechnology names. CELC ranks #2 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$655,974,329
2	CELC	Celcuity Inc. This page	3,127,200	$356,938,608
3	ASND	Ascendis Pharma A/S	1,531,421	$350,281,925
4	ROIV	Roivant Sciences Ltd.	8,285,461	$229,507,269
5	CNTA	Centessa Pharmaceuticals plc	5,258,903	$208,883,627
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,373,795	$206,448,951
7	SYRE	Spyre Therapeutics, Inc.	3,783,225	$190,825,869
8	NUVL	Nuvalent, Inc.	1,580,505	$161,922,737

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$356,938,608	3,127,200	-1.0%	Shares	Sole	2026-05-29
2025-12-31	$315,198,348	3,160,200	+6.9%	Shares	Sole	2026-02-17
2025-09-30	$146,042,158	2,956,319	+10.7%	Shares	Sole	2025-11-14
2025-07-30	$107,625,059	2,670,597	+63.5%	Shares	Sole	2025-08-04
2025-06-30	$21,803,326	1,633,208	-30.9%	Shares	Sole	2025-08-14
2025-03-31	$23,882,640	2,362,279	0.0%	Shares	Sole	2025-08-06
2024-12-31	$30,922,232	2,362,279	0.0%	Shares	Sole	2025-02-14
2024-09-30	$35,221,579	2,362,279	0.0%	Shares	Sole	2024-11-14
2024-06-30	$38,694,130	2,362,279	0.0%	Shares	Sole	2024-08-16
2024-03-31	$51,025,226	2,362,279	+59.5%	Shares	Sole	2024-08-06
2023-12-31	$21,582,541	1,481,300	—	Shares	Sole	2024-02-26
No filing history on record for this holder in this stock.